Open navigation
Search
Search

Select your region

Life Sciences & Healthcare Law Firm in Slovenia

Latest

  • Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation
    12 Feb 2026 6 min read
  • Medical technologies in defence and aerospace: Key themes and emerging questions in regulation
    09 Jan 2026 7 min read
  • Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC
    08 Jan 2026 13 min read

With over 480 international specialist lawyers across CMS and the support of the Life Sciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations we help shape the legal frameworks impacting the life sciences & healthcare sector.

We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice and compliance. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Life Sciences & Healthcare Insights

CMS Expert Guide to advertising of medicines and medical devices

26 Mar 2026 2 min read

Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation

12 Feb 2026 6 min read

Medical technologies in defence and aerospace: Key themes and emerging questions in regulation

09 Jan 2026 7 min read

Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC

08 Jan 2026 13 min read

Digital health apps and telemedicine: Updated CMS Expert Guide for 30 jurisdictions

01 Dec 2025 2 min read

Transposition Time – Update on the EU Member States’ adoption of the new Product Liability Directive

17 Nov 2025 6 min read

CMS Expert Guide to digital health apps and telemedicine

12 Nov 2025 2 min read

Beyond disclosure: how the EU Pay Transparency Directive will reshape employer obligations

17 Sep 2025 6 min read

Events

  • Slovenia
    08 Apr 2026

    CMS at Fordham IP & Policy Conference

  • Slovenia
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring/Summer

  • Slovenia
    28 Apr 2026

    IP Insights webinar series 2026

  • Slovenia
    02 May 2026

    CMS at INTA 2026

Back to top Back to top
Warning: Fraudulent emails and messages